Researchers have warned that the disease can infect cow cells and tissues more effectively than older strains.
Cynata Therapeutics completes patient enrolment in phase 2 trial of CYP-001 in adults with newly diagnosed, high risk aGvHD: Melbourne, Australia Tuesday, December 16, 2025, 14:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback